BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Amniocentesis
,
Fenofibrate
,
rs3825942
,
MYC
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ms 209
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Multiple sclerosis lesions at different stages of inflammation
Lesional and uninvolved normal skin from psoriasis patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive…
MS-209 Schering.
Latent profile analysis of regression-based norms demonstrates relationship of compounding MS sympto…
Development and validation of an in-house database for matrix-assisted laser desorption ionization-t…
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Re…
Carnosine Loading and Periodized Training in MS and HC
Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ